IP Verse

Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product Material - EP2945962

The patent EP2945962 was granted to Prothera Biologics on Apr 17, 2019. The application was originally filed on Jan 17, 2014 under application number EP14740523A. The patent is currently recorded with a legal status of "Revoked".

EP2945962

PROTHERA BIOLOGICS
Application Number
EP14740523A
Filing Date
Jan 17, 2014
Status
Revoked
Jun 23, 2023
Grant Date
Apr 17, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOTESTJan 17, 2020MOREADMISSIBLE

Patent Citations (22) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONUS2003190732
INTERNATIONAL-SEARCH-REPORTUS2011190194
INTERNATIONAL-SEARCH-REPORTUS2011293594
INTERNATIONAL-SEARCH-REPORTUS2012053113
INTERNATIONAL-SEARCH-REPORTWO2005121163
OPPOSITIONCN101274956
OPPOSITIONUS2009292114
OPPOSITIONUS2011190194
OPPOSITIONUS2011293594
OPPOSITIONUS2012053325
OPPOSITIONUS4395396
OPPOSITIONUS4510084
OPPOSITIONUS5457181
OPPOSITIONUS6069236
OPPOSITIONWO0230983
OPPOSITIONWO2005046587
OPPOSITIONWO2005121163
OPPOSITIONWO2012012773
OPPOSITIONWO8905650
OPPOSITIONWO9429334
OPPOSITIONWO9610584
SEARCHUS2012053113

Non-Patent Literature (NPL) Citations (13) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- SALIER J-P ET AL, "The inter-alpha-inhibitor family: From structure to regulation", BIOCHEMICAL JOURNAL, PORTLAND PRESS LTD, GB, (19960101), vol. 315, no. 1, ISSN 0264-6021, pages 1 - 9, XP002241012-
OPPOSITION- CLIFTON et al., "Use of proteomics for validation of the isolation process of clotting factor IX from human plasma", Journal of Proteomics, (20101009), vol. 73, no. 3, pages 678 - 688, XP026814973-
OPPOSITION- DUBIN et al., "Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography", Preparative Biochemistry, (19900000), vol. 20, no. 1, pages 63 - 74, XP009190060-
OPPOSITION- M. STEINBUCH, "IX. Notes on the Production of Plasma Derivatives in France", Vox Sang, (19720800), vol. 23, no. 1-2, pages 56 - 57, XP055674141-
OPPOSITION- "Serum albumin", Wikipedia, (20210622), URL: https://en.wikipedia.org/wiki/Serum_albumin, XP055836025-
OPPOSITION- YANG et al., "Proteomic analysis for process development and control of therapeutic protein separation from human plasma", Electrophoresis, (20090416), vol. 30, no. 7, pages 1185 - 1193, XP055674145
OPPOSITION- HABAL et al., "Isolation of two functionally different kininogens from human plasma-separation from proteinase inhibitors and interaction with plasma kallikrein", Biochemical Pharmacology, (19740815), vol. 23, pages 2291 - 2303, XP023776639
OPPOSITION- BURNOUF et al., "Chromatography in plasma fractionation: benefits and future trends", Journal of Chromatography B, (19950000), vol. 664, doi:10.1016/0378-4347(94)00532-A, pages 3 - 15, XP004043701
OPPOSITION- HOFFER et al., "Improved virus safety and purity of a chromatographically produced Factor IX concentrate by nanofiltration UPA", Journal of Chromatography B, (19950721), vol. 669, no. 2, pages 187 - 196, XP004043805
OPPOSITION- KOVAC et al., "Proteomics as a tool for optimization of human plasma protein separation", Journal of Chromatography A, (20080418), vol. 1194, no. 1, pages 38 - 47, XP022696672
OPPOSITION- BURNOUF et al., "Affinity chromatography in the industrial purification of plasma proteins for therapeutic use", J. Biochem. Biophys. Methods, (20011030), vol. 49, no. 1-3, pages 575 - 586, XP002353092
OPPOSITION- MICHALSKI et al., "Preparation and Properties of a Therapeutic Inter‐Alpha‐Trypsin Inhibitor Concentrate from Human Plasma", Vox Sanguinis, (19941101), vol. 67, no. 4, doi:10.1111/j.1423-0410.1994.tb01269.x, pages 329 - 336, XP002563757
SEARCH- MCCANN K B ET AL, "Evaluation of expanded bed adsorption chromatography for extraction of prothrombin complex from Cohn Supernatant I", BIOLOGICALS, ACADEMIC PRESS LTD., LONDON, GB, vol. 36, no. 4, doi:10.1016/J.BIOLOGICALS.2008.01.002, ISSN 1045-1056, (20080701), pages 227 - 233, (20080310), XP022795225 [A] 1-13 * tables 4-6 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents